封面
市場調查報告書
商品編碼
1186535

全球生育補充劑市場:分析與預測(2022-2028 年)

Fertility Supplement Market: Current Analysis and Forecast (2022-2028)

出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 154 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

在預測期內,全球生育補充劑市場規模預計將以約 7.8% 的複合年增長率增長。

全球不孕症患病率激增和肥胖率上升是推動市場增長的主要因素。 在預測期內,可支配收入的增加和久坐不動的生活方式也對市場產生了積極影響。

本報告研究全球生育補充劑市場,並提供有關市場收入、成分/產品/最終用戶/分銷商/地區的市場洞察、市場動態、公司概況等信息。

內容

第一章市場介紹

第 2 章調查方法和前提條件

  • 孕期保健品市場調查流程
  • 孕期保健品市場研究方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對生育補充劑市場的影響

第 6 章生育補充劑市場收入(十億美元),2020-2028 年(預測)

第 7 章市場洞察:按成分分類

  • 自然的
  • 合成/天然和合成的混合物

第 8 章市場洞察:按產品分類

  • 膠囊
  • 藥片
  • 軟膠囊
  • 粉末
  • 液體

第 9 章市場洞察:最終用戶

第 10 章市場洞察:按分佈

  • 場外交易
  • 處方

第 11 章市場洞察:按地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 其他地區

第 12 章生育補充劑市場:市場動態

  • 市場驅動力
  • 市場問題
  • 影響分析

第 13 章生育補充劑市場:機遇

第 14 章生育補充劑市場:趨勢

第15章需求側與供給側分析

  • 需求方分析
  • 供應方分析

第 16 章價值鏈分析

第 17 章衝突場景

  • 競爭格局
    • 波特的五力分析

第十八章公司簡介

  • Fairhaven Health
  • Coast Science
  • LENUS Pharma GesmbH
  • Orthomol
  • Vitabiotics
  • VH Nutrition LLC
  • TTK HealthCare Ltd
  • The Bird and Be Co. Inc.
  • Bionova
  • Exeltis USA, Inc.

第19章 免責事項

簡介目錄
Product Code: UMME211341

Global Fertility Supplement Market is expected to grow at a significant rate of around 7.8% during the forecast period. Fertility supplement contains nutrients, such as folic acid, fish oil, selenium, vitamin E, vitamin D, and others to enhance the fertility of the individuals. Surge in the prevalence of infertility globally and rising rates of obesity are the key drivers boosting the growth of the market. For instance, according to the World Health Organization, in 2021, there were around 48 million couples, and 186 million individuals suffering from infertility disease globally. Apart from this, an increase in disposable income and the high adoption of a sedentary lifestyle is also having a positive impact on the market during the forecast period.

Fairhaven Health; Coast Science; Lenus Pharma GesmbH; Bionova; Vitabiotics Ltd.; Orthomol; Exeltis USA, Inc.; The Bird and Be Co. Inc.; VH Nutrition LLC, and TTK HealthCare Ltd. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, tablet category to witness higher CAGR during the forecast period"

Based on product, the market is categorized into capsules, tablets, soft gels, powder, and liquids. The tablets segment is expected to grow with high CAGR rates during the forecast period. Excipients in high-quality supplements help in tablet absorption and disintegration. Although the natural coating enhances dissolution, several other factors including efficacy and quality influence absorption. These factors are expected to drive the growth of the market during the forecast period. Apart from this, the product's ease of absorption, cost-effectiveness, and disintegration are other factors propelling the growth of the market.

"Amongst end-user type, the female to hold a significant share in the market in 2020"

On the basis of end-user, the fertility supplement market is segmented into men and women. Women held the maximum share in the global market due to an increase in fertility issues among married infertile women. Moreover, companies are rapidly launching their product in the global market which is also driving the growth of the market during the forecast period. For instance, in May 2020, WellSource Nutraceuticals launched Methyl-NX to specifically address the unique design criteria to support in vitro fertilization and fertility programs. It was created to provide sufficient quantities of bioactive folate, essential B vitamins and omega-3.

"North America to hold a significant share in the market"

In 2020, North America held a significant share of the global fertility supplement market which is due to the rising population of infertile men and women. According to the data from the Centers for Disease Control and Prevention (CDC), in 2017, around 6 million women which are estimated to be around 10% of the US women population have difficulty in conceiving a child. Additionally, in the US, there were more than 15 out of every 100 adults aging 18 or more smoke, according to the CDC. Similarly, the healthcare expenditure of the U.S. is high which is another factor driving the market's growth.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Fertility Supplement Market
  • 2.2. Research Methodology of the Fertility Supplement Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE FERTILITY SUPPLEMENT MARKET

6 FERTILITY SUPPLEMENT MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY INGREDIENT

  • 7.1. Natural
  • 7.2. Synthetic/ Blend of Natural & Synthetic

8 MARKET INSIGHTS BY PRODUCT

  • 8.1. Capsules
  • 8.2. Tablets
  • 8.3. Soft Gels
  • 8.4. Powder
  • 8.5. Liquids

9 MARKET INSIGHTS BY END USER

  • 9.1. Men
  • 9.2. Women

10 MARKET INSIGHTS BY DISTRIBUTION

  • 10.1. OTC
  • 10.2. Prescribed

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World

12 FERTILITY SUPPLEMENT MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 FERTILITY SUPPLEMENT MARKET OPPORTUNITIES

14 FERTILITY SUPPLEMENT MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

  • 18.1. Fairhaven Health
  • 18.2. Coast Science
  • 18.3. LENUS Pharma GesmbH
  • 18.4. Orthomol
  • 18.5. Vitabiotics
  • 18.6. VH Nutrition LLC
  • 18.7. TTK HealthCare Ltd
  • 18.8. The Bird and Be Co. Inc.
  • 18.9. Bionova
  • 18.10. Exeltis USA, Inc.

19 DISCLAIMER